about
TNF-based isolated limb perfusion: a decade of experience with antivascular therapy in the management of locally advanced extremity soft tissue sarcomas.Isolated limb perfusions with tumor necrosis factor and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs.Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure.TNF dose reduction in isolated limb perfusion.Technology insight: Utility of TNF-alpha-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities.Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha.Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma.Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremities.Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases.Isolated limb perfusion using tumour necrosis factor α and melphalan in patients with advanced aggressive fibromatosis.Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: a population-based study.Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastasesTumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors.Risk Factors for Positive Deep Pelvic Nodal Involvement in Patients with Palpable Groin Melanoma Metastases: Can the Extent of Surgery be Safely Minimized? : A Retrospective, Multicenter Cohort Study.Metal stents: a bridge to surgery in hilar cholangiocarcinomaPerfusion and infusion for melanoma in-transit metastases in the era of effective systemic therapy.Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation.The Prognostic Value of Post-operative Serum C-reactive Protein Level for -Survival after Surgery for Colorectal Liver Metastases.mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy.Local excision of rectal cancer after chemoradiation: feasibility depends on the primary stage.The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.Treatment modifications in tumour necrosis factor-α (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas.Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer.Transepidermal Water Loss During Halogen Spotlight Phototherapy in Preterm InfantsAngiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastasesThe use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.Laparoscopic-monitored colonoscopic polypectomy: a multimodality method to avoid segmental colon resectionPrognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosisInfluence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysisUpregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomasReshaping the critical role of surgeons in oncology research
P50
Q33204200-6609B6AB-98F6-40C9-B392-8B04E6400FFDQ33215790-FE5B3CF0-A962-4413-B765-27EDBE62BD1BQ33217531-C44EC4BA-C6BB-49C3-BE69-50E1F61AB38FQ33221700-72110C4F-58FC-4FB7-9B7F-09F67CD49D6AQ33233270-47D8E895-0BEF-410C-8218-2F3B79228BBDQ33235619-4EA4B75C-55BB-49B9-8CB4-4B7EB550448FQ33309291-93B71148-8437-4D26-B6B6-AF6FCF4470EAQ33410907-8D983099-9E6F-4ED7-9AB0-81FB0BFE6AF6Q33955599-BE44A09A-EDF4-4765-A2BE-8930A3A7FD98Q34665261-A5D7B523-2BF2-4B9F-8BD8-9243F9BE5D9EQ34670333-A586CB24-FC1F-432F-ACC3-113B3E807F93Q35225671-6C7BBA55-962F-4458-AE82-400F8EC8ABC4Q35677877-F73A5FEB-8758-4BB4-8668-77C9CB78484DQ35798826-7AA0EB0F-6CEF-4AB2-996E-EACF287E6BC5Q36391793-DCB777A8-37B6-4262-98E5-2B9A339B4902Q36786161-1D4669C4-00DB-498F-9F6E-42754CD07610Q38493981-7F3A3038-15FA-4213-AF7C-60D1C9ACE89CQ40565521-6C69A953-074B-416E-B7FA-7493F490AED3Q40922054-66B7EDF0-4602-48DC-ACAF-7E3506A3A1CDQ41130353-FB4E9B24-4937-4C66-ABEC-52D448C3F525Q41788611-D9C91114-259B-4A19-B42E-DF5A4D224CFEQ42639721-0DD03138-09CB-4A69-9AA7-476BFC5FD3CCQ44915946-37FD1AA9-FA79-4547-952D-62C5ADEC9869Q53656510-8A54D091-8C1A-4664-81C5-653A7B428BC2Q55250324-AF29A5BB-6C42-4047-B822-1453B95A3090Q59317302-8C1D5E98-CC67-4532-A3FB-D4E85AB0E504Q64232821-EF8736D4-95E0-4009-B4BD-BB3C6B8B7ADAQ64984888-7940F5CD-E7A3-4DB7-B85A-C1D6431A7195Q82525644-7098FFB9-BD67-4205-9FBD-A1F52395A666Q85848565-616B73ED-C0CC-484B-96D7-52E2682DACEDQ87009550-E8D1CD36-4E70-4287-8B19-495B922D10F8Q90913602-0D38C1B9-919D-4124-BC1A-21B44933135CQ90929542-D6013A40-83D9-4E9F-91D8-12715A611EB2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dirk J Grünhagen
@ast
Dirk J Grünhagen
@en
Dirk J Grünhagen
@es
Dirk J Grünhagen
@nl
Dirk J Grünhagen
@sl
type
label
Dirk J Grünhagen
@ast
Dirk J Grünhagen
@en
Dirk J Grünhagen
@es
Dirk J Grünhagen
@nl
Dirk J Grünhagen
@sl
prefLabel
Dirk J Grünhagen
@ast
Dirk J Grünhagen
@en
Dirk J Grünhagen
@es
Dirk J Grünhagen
@nl
Dirk J Grünhagen
@sl
P106
P108
P31
P496
0000-0001-8293-6002